Company registration number 11653696 (England and Wales)
APOBEC DISCOVERY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
APOBEC DISCOVERY LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 5
APOBEC DISCOVERY LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
4
170,495
102,956
Cash at bank and in hand
445,526
1,070,696
616,021
1,173,652
Creditors: amounts falling due within one year
5
(92,338)
(15,028)
Net current assets
523,683
1,158,624
Capital and reserves
Called up share capital
49
49
Share premium account
2,992,640
2,992,640
Profit and loss reserves
(2,469,006)
(1,834,065)
Total equity
523,683
1,158,624
For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 5 January 2026 and are signed on its behalf by:
Mr J W Edwards
Director
Company registration number 11653696 (England and Wales)
APOBEC DISCOVERY LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 OCTOBER 2025
- 2 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 November 2023
44
2,492,645
(1,408,289)
1,084,400
Year ended 31 October 2024:
Loss and total comprehensive income
-
-
(425,776)
(425,776)
Issue of share capital
5
499,995
-
500,000
Balance at 31 October 2024
49
2,992,640
(1,834,065)
1,158,624
Year ended 31 October 2025:
Loss and total comprehensive income
-
-
(634,941)
(634,941)
Balance at 31 October 2025
49
2,992,640
(2,469,006)
523,683
APOBEC DISCOVERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 3 -
1
Accounting policies
Company information
APOBEC Discovery Limited is a private company limited by shares incorporated in England and Wales. The registered office is Victory House, Vision Park, Histon, Cambridge, Cambridgeshire, CB24 9ZR.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.
The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.
1.2
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.3
Taxation
The tax expense represents the sum of the tax currently payable.
APOBEC DISCOVERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 4 -
Current tax
The Company currently surrenders losses relating to eligible UK research and development expenses for a cash rebate. The cash rebate rate will reduce in respect of qualifying expenditure incurred in accounting periods beginning on, or after, 1 April 2023. The tax credit is recognised within taxation in the profit and loss account in the year in which the corresponding costs were incurred. Amounts not yet received are recognised within debtors in the balance sheet.
1.4
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.5
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
1.6
The company operates a defined contribution plan for its eligible employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once contributions have been paid, the Company has no further payment obligations.
1.7
Research and development tax relief
As the company's principal activity is research and development, the company incurs significant costs that are eligible for tax relief under the HMRC SME and RDEC tax relief programs. Qualifying expenditures largely comprise of employment costs for research staff, consumables, certain other internal costs directly related to research projects and research and development acitivities subcontracted to third parties.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
APOBEC DISCOVERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 5 -
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
7
6
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Corporation tax recoverable
131,905
93,047
Other debtors
34,284
9,876
Prepayments and accrued income
4,306
33
170,495
102,956
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
64,122
9,930
Other creditors
28,216
5,098
92,338
15,028
6
Share options
On the 23 October 2024 the company granted share options to purchase ordinary shares to a number of its employees. A third of the options vested on the date of the grant and the remaining thirds will vest on each of the next two anniversaries of the date of the grant. The option is exercisable from the date of grant and expires on the tenth anniversary of the grant. The settlement option is equity not cash.
In the opinion of the directors, the options will only be exercised if the company's shares can be sold at a price higher than the option exercise price. At the balance sheet date the directors are unable to assess with the reasonable confidence whether this outcome will be reached. On this basis the share options have not been recognised in the financial statements. The position will be reviewed at subsequent company year ends and the share options accounted for as required.